009420.KS
Price:
$56500
Market Cap:
$2.87T
HANALL BIOPHARMA Co., Ltd. engages in the manufacture and sale of synthetic drug and biopharmaceuticals. It offers products such as medicine for digestion, high blood pressure, cerebrovascular disease, myocardial infarction, anti-diabetics, antibiotics, gastrointestinal, bone structure, erectile dysfunction, hives, and other pharmaceutical products. The company was founded by Byeong-Tae Kim on November 20, 1973 and is headquartered in Daejeon, South Korea.
Industry
Medical - Pharmaceuticals
IPO Date
2000-01-04
Stock Exchange
KSC
Ticker
009420.KS
According to Hanall Biopharma Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -15.48%. This represents a change of 302.12% compared to the average of -3.85% of the last 4 quarters.
The mean historical ROE of Hanall Biopharma Co., Ltd. over the last ten years is 3.75%. The current -15.48% ROE has changed -512.75% with respect to the historical average. Over the past ten years (40 quarters), 009420.KS's ROE was at its highest in in the December 2019 quarter at 4.43%. The ROE was at its lowest in in the June 2026 quarter at -11.90%.
Average
3.75%
Median
2.38%
Minimum
-3.44%
Maximum
13.66%
Discovering the peaks and valleys of Hanall Biopharma Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.16%
Maximum Annual ROE = 13.66%
Minimum Annual Increase = -156.90%
Minimum Annual ROE = -3.44%
| Year | ROE | Change |
|---|---|---|
| 2025 | -3.44% | 220.67% |
| 2024 | -1.07% | -156.90% |
| 2023 | 1.88% | 1.16% |
| 2022 | 0.15% | -97.25% |
| 2021 | 5.44% | -50.09% |
| 2020 | 10.90% | -20.15% |
| 2019 | 13.66% | 383.79% |
| 2018 | 2.82% | -46.01% |
| 2017 | 5.23% | 169.28% |
| 2016 | 1.94% | -126.12% |
The current ROE of Hanall Biopharma Co., Ltd. (009420.KS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.88%
5-year avg
0.59%
10-year avg
3.75%
Hanall Biopharma Co., Ltd.’s ROE is less than Daewoong pharmaceutical Co.,Ltd (19.67%), less than Oscotec Inc. (54.21%), less than Celltrion Pharm, Inc. (9.82%), less than ST Pharm Co.,Ltd. (12.84%), greater than D&D Pharmatech (-23.74%), greater than OliX Pharmaceuticals,Inc (-8.34%), less than Chong Kun Dang Pharmaceutical Corp. (7.97%), greater than GC Biopharma Corp. (-4.01%), less than DongKook Pharmaceutical Co., Ltd. (11.37%), less than Ildong Pharmaceutical Co., Ltd. (17.72%),
| Company | ROE | Market cap |
|---|---|---|
| 19.67% | $1.37T | |
| 54.21% | $1.40T | |
| 9.82% | $1.84T | |
| 12.84% | $2.08T | |
| -23.74% | $2.33T | |
| -8.34% | $1.99T | |
| 7.97% | $881.48B | |
| -4.01% | $1.39T | |
| 11.37% | $801.62B | |
| 17.72% | $425.67B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hanall Biopharma Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hanall Biopharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Hanall Biopharma Co., Ltd.'s ROE?
How is the ROE calculated for Hanall Biopharma Co., Ltd. (009420.KS)?
What is the highest ROE for Hanall Biopharma Co., Ltd. (009420.KS)?
What is the 3-year average ROE for Hanall Biopharma Co., Ltd. (009420.KS)?
What is the 5-year average ROE for Hanall Biopharma Co., Ltd. (009420.KS)?
How does the current ROE for Hanall Biopharma Co., Ltd. (009420.KS) compare to its historical average?